Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

Prostate Cancer Screening Benefits Are Small, Says US Report
The recently released results of two large randomized trials suggest there are no big benefits from prostate cancer screening, and if
generic viagra online
PEPFAR Funds Used To Encourage Swaziland Couples To Get Tested Together
CNN examines the success of an HIV testing campaign in Swaziland that urges couples to get tested together. "The nationwide initiative - funded by the United States government and implemented by global charity "Population Services International" (PSI) - is aimed at couples because tests can be useless if partners are not aware of the others" HIV status," CNN writes.
News of the day
Risk Factors Of Cardiovascular Disease Rising In Poor, Young
Cardiovascular disease is increasing in adults under 50 and those of lower socioeconomic status, despite recent trends which show that cardiovascular disease is declining in Canada overall, say researchers at the Peter Munk Cardiac Centre. Untreated cardiovascular disease can lead to heart failure, coronary artery disease and death, and is the most common cause of hospitalization in North America.
Oncology

Comprehensive Review On Sulfonylureas In The Latest Issue Of Diabetic Hypoglycemia (09 June 2009)

The latest issue of the online journal Diabetic Hypoglycemia features an authoritative review on sulfonylureas by Professor Ian Campbell, a leading expert in oral hypoglycemia therapy. Professor Campbell"s review focuses on sulfonylurea-induced hypoglycemia (SIH), which is a well-recognized side-effect of this class of therapy for type 2 diabetes. In the review he discusses the incidence of SIH, with particular reference to the different sulfonylureas. He also reflects on the morbidity and mortality seen with SIH, precipitating risk factors, treatment of SIH, and education of patients and medical staff in the prevention of SIH. This issue of Diabetic Hypoglycemia also includes a case study on recurring hypoglycemia associated with glibenclamide, by Professor Campbell. Dr Rory McCrimmon of the Editorial Board reviews the literature on blood glucose monitoring in hypoglycemia, in an editorial entitled "What we"re learning from continuous glucose monitoring". This issue of Diabetic Hypoglycemia also features an "In profile" interview with Professor Stephanie Amiel, a leading expert in the use of neuroimaging in diabetes and hypoglycemia. About the Journal Diabetic Hypoglycemia is an influential online diabetes journal. The Editorial Board of hypoglycemia experts peer review all Journal content. The Board is led by Editor-in-Chief Professor Brian Frier (Edinburgh, UK), with Associate Editors: Professor Simon Heller (Sheffield, UK), Professor Christopher Ryan (Pittsburgh, USA) and Dr Rory McCrimmon (Yale, USA). Diabetic Hypoglycemia is published three times a year, providing an interactive forum for readers to share practical knowledge and opinions on the rapidly evolving field of hypoglycemia. To explore the Diabetic Hypoglycemia website and its key features, our guided tour can be activated by clicking the following link here. Diabetic Hypoglycemia is published by ESP Bioscience. Support for the journal is provided by an unrestricted educational grant from Novo Nordisk A/S (Bagsvaerd, Denmark). ESP Bioscience


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009